Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Pract Radiat Oncol. 2019 Nov 29;10(4):265–273. doi: 10.1016/j.prro.2019.11.007

Table 1.

Benchmark QA resubmission rates

No. of resubmissions Sites (n = 352) 3DCRT (n = 205) IMRT (n = 100) SIB (n = 119)

0 278* (79.0%) 168 (82.0%) 83 (83.0%) 98 (82.4%)
>1 74 (21.0%) 37 (18.0%) 17 (17.0%) 21 (17.6%)
1 61 (17.3%) 30 (14.6%) 15 (15.0%) 17 (14.3%)
2 12 (3.4%) 7 (3.4%) 2 (2.0%) 4 (3.4%)
3 1§ (0.3%)

Abbreviations’. 3DCRT = 3-dimensional conformai radiation therapy; IMRT = intensity-modulated radiation therapy; SIB = simultaneous integrated boost.

*

Two sites failed on first benchmark submission and never resubmitted for any modality.

Three, 6, and 5 sites failed on first submission and did not resubmit for 3DCRT, IMRT, and SIB, respectively.

One of these 2 sites never passed the IMRT benchmark.

§

One site had one 3DCRT resubmission and 2 SIB resubmissions.